Pathophysiological consequences of HIF activation: HIF as a modulator of fibrosis

Annals of the New York Academy of Sciences

Volumn 1177, Issue , 2009, Pages 57-65

  Haase, Volker H ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic kidney disease (CKD); Epithelial to mesenchymal transition (EMT); Extracellular matrix; Fibrosis; Hypoxia inducible factor (HIF); Lysyl oxidases; Transcriptional repressors

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; PROTEIN LYSINE 6 OXIDASE;

CELL MOTILITY; CELL PROTECTION; CONFERENCE PAPER; ENZYME INHIBITION; FIBROGENESIS; FIBROSIS; IN VITRO STUDY; IN VIVO STUDY; KIDNEY INJURY; PATHOPHYSIOLOGY; TISSUE INJURY; URETER OBSTRUCTION;

EID: 70350389951     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05030.x     Document Type: Conference Paper

References (45)

1. Haase, V.H. 2006. Hypoxia-inducible factors in the kidney. Am. J. Physiol. Renal. Physiol. 291: F271-F281.
2. Eckardt, K.U. et al. 2005. Role of hypoxia in the pathogenesis of renal disease. Kidney Int. Suppl. S46-S51.
3. Heyman, S.N. et al. 2008. Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease. Am. J. Nephrol. 28: 998-1006.
4. Nangaku, M. et al. 2008. Hypoxia and hypoxiainducible factor in renal disease. Nephron. Exp. Nephrol. 110: e1-e7.
5. Edlund, J. et al. 2009. Reduced oxygenation in diabetic rat kidneysmeasured byT2 weighted magnetic resonance micro-imaging. Adv. Exp. Med. Biol. 645: 199-204.
6. Ries,M. et al. 2003. Renal diffusion and BOLDMRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J. Magn. Reson. Imaging 17: 104-113.
7. Higgins, D.F. et al. 2007. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-tomesenchymal transition. J. Clin. Invest. 117: 3810-3820.
8. Kojima, I. et al. 2007. Protective role of hypoxiainducible factor-2alpha against ischemic damage and oxidative stress in the kidney. J. Am. Soc. Nephrol. 18: 1218-1226.
9. Hill, P. et al. 2008. Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemiareperfusion injury. J. Am. Soc. Nephrol. 19: 39-46.
10. Kimura, K. et al. 2008. Stable expression of HIF- 1alpha in tubular epithelial cells promotes interstitial fibrosis. Am. J. Physiol. Renal. Physiol. 295: F1023-F1029.
11. Manotham, K. et al. 2004. Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int. 65: 871-880.
12. Liu, Y. 2004. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J. Am. Soc. Nephrol. 15: 1-12.
13. Iwano, M. et al. 2002. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110: 341-350.
14. Lin, S.L. et al. 2008. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am. J. Pathol. 173: 1617-1627.
15. Zeisberg, E.M. et al. 2008. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J. Am. Soc. Nephrol. 19: 2282-2287.
16. Chen, X. et al. 2003. STAT proteins mediate angiotensin II-induced production of TIMP-1 in human proximal tubular epithelial cells. Kidney Int. 64: 459-467.
17. Yu, L. et al. 2003. TGF-beta isoforms in renal fibrogenesis. Kidney Int. 64: 844-856.
18. Kalluri, R. & E.G. Neilson. 2003. Epithelialmesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112: 1776-1784.
19. Orphanides, C. et al. 1997. Hypoxia stimulates proximal tubular cell matrix production via a TGFbeta1- independent mechanism. Kidney Int. 52: 637-647.
20. Kietzmann, T. et al. 1999. Induction of the plasminogen activator inhibitor-1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia-inducible factor-1 in rat hepatocytes. Blood 94: 4177-4185.
21. Higgins, D.F. et al. 2004. Hypoxic induction of Ctgf is directly mediated byHif-1.Am. J. Physiol. RenalPhysiol. 287: F1223-F1232.
22. Sanchez-Elsner, T. et al. 2001. Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression. J. Biol. Chem. 276: 38527-38535.
23. Sanchez-Elsner, T. et al. 2002. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways. J. Biol. Chem. 277: 43799-43808.
24. Sanchez-Elsner, T. et al. 2004. A cross-talk between hypoxia and TGF-beta orchestrates erythropoietin gene regulation through SP1 and SMADs. J. Mol. Biol. 336: 9-24.
25. Falanga, V. et al. 2002. Low oxygen tension stimulates collagen synthesis and COL1A1 transcription through the action of TGF-beta1. J. Cell. Physiol. 191: 42-50.
26. Saed, G.M. et al. 1999. Alteration of type I and III collagen expression in human peritoneal mesothelial cells in response to hypoxia and transforming growth factor-beta1. Wound Repair. Regen. 7: 504-510.
27. Bottinger, E.P. & M. Bitzer. 2002. TGF-beta signaling in renal disease. J. Am. Soc. Nephrol. 13: 2600-2610.
28. Zhang, H. et al. 2003. Cellular response to hypoxia involves signaling via SMAD proteins. Blood 101: 2253-2260.
29. Sahlgren, C. et al. 2008. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc. Natl. Acad. Sci. USA 105: 6392-6397.
30. Kaidi, A. et al. 2007. Interaction between betacatenin and HIF-1 promotes cellular adaptation to hypoxia. Nat. Cell Biol. 9: 210-217.
31. Peinado, H. et al. 2007. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer 7: 415-428.
32. Moreno-Bueno, G. et al. 2006. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res. 66: 9543-9556.
33. Jorda, M. et al. 2005. Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J. Cell Sci. 118: 3371-3385.
34. Taki, M. et al. 2006. Involvement of Ets-1 transcription factor in inducing matrix metalloproteinase-2 expression by epithelial-mesenchymal transition in human squamous carcinoma cells. Int. J. Oncol. 28: 487-496.
35. Imai,T. et al. 2003. Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am. J. Pathol. 163: 1437-1447.
36. Krishnamachary, B. et al. 2006. Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res. 66: 2725-2731.
37. Evans, A.J. et al. 2007. VHL promotes E2 box-dependent E-cadherin transcription by HIFmediated regulation of SIP1 and snail. Mol. Cell Biol. 27: 157-169.
38. Esteban, M.A. et al. 2006. Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. Cancer Res. 66: 3567-3575.
39. Boutet, A. et al. 2006. Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. Embo J. 25: 5603-5613.
40. Gort, E.H. et al. 2008. The TWIST1 oncogene is a direct target of hypoxia-inducible factor-2alpha. Oncogene 27: 1501-1510.
41. Yang, M.H. et al. 2008. Direct regulation of TWIST by HIF-1alpha promotesmetastasis. Nat. Cell Biol. 10: 295-305.
42. Sun, S. et al. 2009. Hypoxia-inducible factor- 1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-tomesenchymal transition. Kidney Int 75: 1278-1287.
43. Erler, J.T. et al. 2006. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440: 1222-1226.
44. Lucero, H.A. & H.M. Kagan. 2006. Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell Mol. Life Sci. 63: 2304-2316.
45. Peinado, H. et al. 2005. A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression. Embo J. 24: 3446-3458.